More than three decades after Hong Kong and Singapore separately embarked on growing biotechnology sectors at almost the same time, their outcomes have proven dramatically different.Observers say Hong Kong’s efforts have sputtered and lagged behind Singapore’s strides in setting up a range of research institutions, attracting top talent and manufacturers, creating jobs and providing a launch pad for start-ups.There is now a new urgency for Hong Kong to prove its prowess, given China’s five-year…